Access to anti-retroviral drugs, male in Bhutan

Bhutan: Access to anti-retroviral drugs, male was 62.0% in 2024. ◆ Volatile

Latest (2024)
62.0%
Change on year
up 3.3%
World rank
94th
of 141 countries
All-time high
62.0%
in 2024
All-time low
0.0%
in 2000
Years of data
25
2000–2024

Access to anti-retroviral drugs, male in Bhutan, 2000–2024

02040602000201220242000: 0 %2001: 0 %2002: 0 %2003: 0 %2004: 1 %2005: 1 %2006: 4 %2007: 6 %2008: 8 %2009: 9 %2010: 13 %2011: 14 %2012: 18 %2013: 24 %2014: 28 %2015: 38 %2016: 41 %2017: 49 %2018: 56 %2019: 55 %2020: 55 %2021: 56 %2022: 57 %2023: 60 %2024: 62 %

Source: UNAIDS estimates. Measured in %.

Analysis

In 2024, access to anti-retroviral drugs, male in Bhutan stood at 62.0%. That is the highest value across all 25 years on record.

The figure is up 3.3% on the previous year and up 121.4% over ten years.

Over the whole period, access to anti-retroviral drugs, male in Bhutan peaked at 62.0% in 2024 and was at its lowest, 0.0%, in 2000.

Bhutan ranks 94th of 141 countries on this measure, in the middle of the range.

The series is highly variable year to year, so single readings are best treated with caution.

Access to anti-retroviral drugs, male in Bhutan, year by year

Annual values for Access to anti-retroviral drugs, male (%) in Bhutan, 2000 to 2024.
Year % Change
2000 0.0%
2001 0.0%
2002 0.0%
2003 0.0%
2004 1.0%
2005 1.0% +0.0%
2006 4.0% +300.0%
2007 6.0% +50.0%
2008 8.0% +33.3%
2009 9.0% +12.5%
2010 13.0% +44.4%
2011 14.0% +7.7%
2012 18.0% +28.6%
2013 24.0% +33.3%
2014 28.0% +16.7%
2015 38.0% +35.7%
2016 41.0% +7.9%
2017 49.0% +19.5%
2018 56.0% +14.3%
2019 55.0% -1.8%
2020 55.0% +0.0%
2021 56.0% +1.8%
2022 57.0% +1.8%
2023 60.0% +5.3%
2024 62.0% +3.3%

Averages by decade

DecadeAverage LowestHighest Years
2000s 2.9% 0.0% 9.0% 10
2010s 33.6% 13.0% 56.0% 10
2020s 58.0% 55.0% 62.0% 5

Countries ranked near Bhutan

  1. 92 Bulgaria 63.0% compare
  2. 92 Somalia 63.0% compare
  3. 94 Guinea-Bissau 62.0% compare
  4. 94 Timor-Leste 62.0% compare
  5. 97 Central African Republic 61.0% compare
  6. 97 Costa Rica 61.0% compare
  7. 97 Lao People's Democratic Republic 61.0% compare
  8. 97 Montenegro 61.0% compare
  9. 97 Paraguay 61.0% compare

See the full ranking of 160 places →

More gender data for Bhutan

All data for Bhutan →

Frequently asked questions

What is access to anti-retroviral drugs, male in Bhutan?
Access to anti-retroviral drugs, male in Bhutan was 62.0% in 2024, according to UNAIDS estimates.
What is the highest access to anti-retroviral drugs, male recorded in Bhutan?
The highest recorded value was 62.0% in 2024.
What is the lowest access to anti-retroviral drugs, male recorded in Bhutan?
The lowest recorded value was 0.0% in 2000.
How does Bhutan rank for access to anti-retroviral drugs, male?
Bhutan ranks 94th out of 141 countries with data for 2024.
Is access to anti-retroviral drugs, male rising or falling in Bhutan?
Over the last ten years it is up 121.4%. The long-run trend across the full record is volatile.
Where does this Bhutan data come from?
The figures come from UNAIDS estimates, published as part of Access to anti-retroviral drugs, male (%). Statizoid updates them automatically from the source API.

Download this data

CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).

Share, cite or embed this page

Cite this page

Access to anti-retroviral drugs, male in Bhutan. Statizoid, drawing on UNAIDS estimates. Retrieved 10 September 2026, from https://gender.statizoid.com/stat/access-to-anti-retroviral-drugs-male-percent/bhutan/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY 4.0 (World Bank Open Data); please keep the attribution.

<a href="https://gender.statizoid.com/stat/access-to-anti-retroviral-drugs-male-percent/bhutan/">Access to anti-retroviral drugs, male in Bhutan</a> — Statizoid

About this data

Indicator
Access to anti-retroviral drugs, male (%)
Unit
%
Source
UNAIDS estimates
Licence
CC BY 4.0 (World Bank Open Data)
Coverage
160 places, 3,923 data points, 2000–2024
Last refreshed

The percentage of adult males living with HIV who are receiving antiretroviral therapy.